Pharmaceut_MDPI Profile Banner
Pharmaceuticals MDPI Profile
Pharmaceuticals MDPI

@Pharmaceut_MDPI

Followers
2K
Following
913
Media
5K
Statuses
6K

Pharmaceuticals (ISSN 1424-8247): open access journal of @medicinal_chemistry and related @drug_sciences. Editor-in-Chief: Prof. Dr. Amélia Pilar Rauter

Basel, Switzerland
Joined February 2016
Don't wanna be here? Send us removal request.
@Pharmaceut_MDPI
Pharmaceuticals MDPI
17 hours
Welcome to read the #Published paper #Pharmaceuticals Iron-Based Metal-Organic Frameworks as Multiple Cascade Synergistic Therapeutic Effect Nano-Drug Delivery Systems for Effective Tumor Elimination by Zheng et al. Enjoy reading: https://t.co/vTCa32smZ4
0
0
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
18 hours
Welcome to read the #Published paper #Pharmaceuticals The Development of Magnolol-Loaded Intravenous Emulsion with Low Hepatotoxic Potential by Gostyńska et al. Enjoy reading: https://t.co/cFPoxqHJRt
0
0
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
19 hours
📢#Specialissue: Self-Assembling #Materials for Next-Generation #Biopharmaceuticals ⏰Deadline: 25 June 2026 🎓Guest Editors: Dr. Leming Sun 📖Find out more at https://t.co/PzQQ2qeP9X @MDPIBiologySubj
0
1
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
20 hours
Welcome to read the #Published paper #Pharmaceuticals Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients by Chiang et al. Enjoy reading: https://t.co/7QkwTD974m
1
0
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
21 hours
📢#Specialissue: #Pharmaceutical #Process #Engineering: Experimental and Computational Innovation ⏰Deadline: 22 December 2025 🎓Guest Editors: Dr. Marcial Gonzalez and Dr. Francesco Destro 📖Find out more at https://t.co/PPNefaFyoa @MDPIBiologySubj
0
0
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
22 hours
🌟 Highly Cited Special Issue Highlight! 🌟 💖 Discover the Special Issue Book: “Therapeutic Potential of Silver Nanoparticles (AgNPs)” 🔬 👥 Guest Editor: Dr. Goreti Pereira 📖 Explore this curated collection of Medicinal Chemistry at: https://t.co/ee6n5LSSvZ
0
0
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
2 days
Welcome to read #Published paper Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors by Leupe et al. From Topical: https://t.co/KXQ4GjZUZc Enjoy reading: https://t.co/nmQVQOpSYk
0
0
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
2 days
Welcome to read the #Published paper How Regulation 536/2014 Is Changing Academic Research with Therapeutic Radiopharmaceuticals: A Local Experience by Di Iorio et al. From Topical Collection: https://t.co/KXQ4Gk0sOK Enjoy reading: https://t.co/AwmZU3gxS0
0
0
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
2 days
💖 Discover Natural Products as potential candidates to improve cardio-metabolic outcomes! We proudly highlight "Gut-Derived Metabolite, TMAO in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics" by Shanmugham et al. Read more: https://t.co/9szM7oyRbY
0
0
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
2 days
Welcome to read the #Published paper Topical Treatments for Rare Genetic Dermatological Diseases: A Narrative Review by Oliveira et al. From Topical Collection: https://t.co/81QDzyq9FG Enjoy reading: https://t.co/RoVKn4B36S
0
0
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
2 days
📢#Specialissue: Application of #Nuclear #Magnetic #Resonance (#NMR) in #Drug #Development ⏰Deadline: 25 May 2026 🎓Guest Editors: Dr. Vladimir M. Gelev 📖Find out more at https://t.co/ntodBzOk3j @MDPIBiologySubj
0
0
1
@Pharmaceut_MDPI
Pharmaceuticals MDPI
2 days
Welcome to read the #Published paper Bioactive Compounds Derived from Plants and Their Medicinal Potential by Oliveira et al. From Special Issue: https://t.co/31Qn8DFHzS Enjoy reading: https://t.co/g2b5YFHM0n
0
1
3
@Pharmaceut_MDPI
Pharmaceuticals MDPI
2 days
📢#Specialissue: #Orodispersible and #Innovative #Dosage #Forms: Advances in Preparation Technologies, Direct Compression, and Co-Processed Excipients ⏰Deadline: 10 December 2025 🎓Guest Editors: Dr. Witold Brniak and Prof. Dr. Aleksander Mendyk https://t.co/jdqKUKs15B
0
0
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
3 days
Welcome to read the #Published paper #Pharmaceuticals Successful Treatment of Complicated Influenza A(H3N2) Virus Infection and Rhabdomyolysis with Compassionate Use of IV Zanamivir by Alchikh et al. Enjoy reading: https://t.co/NWoEpSz2EX
0
0
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
3 days
🌟 We are delighted to present our SI: “The 20th Anniversary of Pharmaceuticals — Multi-Targeted Natural Products as Therapeutics” 🎉 This SI highlights the most recent breakthroughs in Natural Products. Guest Editors: Dr. Elena Y. Enioutina et al. https://t.co/AKTfoV9n3A
0
0
1
@Pharmaceut_MDPI
Pharmaceuticals MDPI
3 days
Welcome to read the #Published paper #Pharmaceuticals Polarization of HIV-1- and CMV-Specific IL-17-Producing T Cells among People with HIV under Antiretroviral Therapy with Cannabis and/or Cocaine Usage by Castro et al. Enjoy reading: https://t.co/KXkZr3hfAO
0
0
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
3 days
📢#Specialissue: #Polysulfide #Pharmacology: Biological Effects and Therapeutic Potential in #Pain, #Inflammation, and #CNS Disorders ⏰Deadline: 30 June 2026 🎓Guest Editors: Dr. Gábor Pozsgai 📖Find out more at https://t.co/5thXQb3Wit @MDPIBiologySubj
0
0
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
3 days
Welcome to read the #Published paper #Pharmaceuticals Rapamycin as a Potential Alternative Drug for Squamous Cell Gingiva Carcinoma (Ca9-22): A Focus on Cell Cycle, Apoptosis and Autophagy Genetic Profile by Papadakos et al. Enjoy reading: https://t.co/hhYMH4ddZA
0
0
2
@Pharmaceut_MDPI
Pharmaceuticals MDPI
3 days
📢#Specialissue: New Platforms for #Cancer #Treatment—Emerging Advances ⏰Deadline: 10 December 2025 🎓Guest Editors: Dr. Fernanda Karoline Vieira da Silva Torchelsen et al. 📖Find out more at https://t.co/ovJXlv2INn @MDPIBiologySubj
0
0
3
@Pharmaceut_MDPI
Pharmaceuticals MDPI
6 days
Welcome to read the #Published paper #Pharmaceuticals Effectiveness and Bioinformatics Analysis of Yiqi and Blood-Activating Therapy Combined with Chemotherapy in the Treatment of Non-Small Cell Lung Cancer by Xu et al. Enjoy reading: https://t.co/7xSOaHjFYp
0
0
2